Skip to main content
OpenTrials
Completed

NCT Number: NCT05985031

Reciprocal Inhibition Versus Reciprocal Facilitation In Spinal Cord Injury Patients

Reciprocal inhibition is a medulla spinalis control mechanism that facilitates motor activities in healthy people. As the agonist muscle contracts, the antagonist muscle is inhibited so that the agonist action can take place properly. In the literature, there are studies showing that in patients with upper motor neuron lesions, this reverses, and reciprocal facilitation occurs instead of inhibition. However, there is no clear situation in this regard, there is a need for more methodologically sound studies. Our aim in this study is to investigate the presence of reciprocal facilitation in patients with spinal cord lesions (SCL).

Completed

Looking for future studies?

Notify Me

Key information

Age range

25 year–60 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

İstanbul Physical Therapy Training and Research Hospital

Istanbul, 34180, Turkey (Türkiye)

About this study

Reciprocal inhibition is a spinal segmental control mechanism that facilitates motor activities in healthy people and is also used in treating spasticity. Considering the current literature, there are some studies claiming that this is reversed in patients with upper motor neuron lesions and that there is reciprocal facilitation instead of inhibition. However, the proposed evidence is not convincing. Our aim in this study was to investigate the presence of reciprocal facilitation in detail in patients with upper motor neuron lesions. This study was conducted in five patients with spinal cord lesions and five healthy individuals. Both the tibialis anterior and soleus muscles of the cases were recorded using surface and multi-motor unit electromyography (EMG) electrodes. To elicit an H reflex in the soleus muscle, an electric current was delivered through the popliteal fossa using the monopolar technique. The Achilles tendon was tapped with the reflex hammer to elicit a T reflex. Since the H-reflex and T-reflex responses were detected in the tibialis anterior muscle surface and multi-motor unit EMG recordings, the findings were evaluated as direct stimulation, cross-talk, and reciprocal facilitation. Methodologically, This research aimed to be a guiding study for future studies.

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Patients with spinal cord injury between the ages of 18-60
  • A minimum of 6 months of SCL history
  • Soleus spasticity

Exclusion criteria

  • Patients with premorbid neuromuscular disease
  • History of autonomic dysreflexia
  • Patients in the spinal shock period
  • Those who have a coronavirus disease clinic
  • Less than 2 hours sitting tolerance

Treatment and study plan

Tendon tap

Diagnostic Test

While examining the T reflex, the ankle was held passively in neutral, dorsiflexion and plantar flexion positions by the investigator.

Other names: T-reflex

Tibial nerve stimulation

Diagnostic Test

H-reflex responses were examined by tibial nerve stimulation

Other names: H-reflex

Primary outcomes

  1. Reciprocal Inhibition

    Time frame: up to 2 weeks

    H reflex and T reflex tests were performed in the soleus and tibialis anterior muscle, and it was evaluated whether there was reciprocal inhibition in the tibialis anterior muscle.

Secondary outcomes

  1. H-reflex

    Time frame: up to 2 weeks

    Electric current was delivered through the popliteal fossa to tibial nerve for eliciting the soleus H-reflex

  2. T-reflex

    Time frame: up to 2 weeks

    The Achilles tendon was hit with using a reflex hammer to elicit the soleus T-reflex.

Sponsors and collaborators

Lead sponsor

Istanbul Physical Medicine Rehabilitation Training and Research Hospital

Other Gov

Registry information

Official study title

Does Reciprocal Inhibition, a Rehabilitation Technique, Convert to Reciprocal Facilitation in Patients With Upper Motor Neuron Lesions?

Important dates

Study start
2023
Primary completion
2023
Study completion
2023
First posted
Aug 14, 2023
Registry last updated
Aug 15, 2023

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.